top of page

June 2024 - Qalsody (Tofersen) Approved For Use in Europe


Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a Rare, Genetic Form of ALS. Read more here.


Comments


bottom of page